About Divine Savior
Divine Savior is a company based in Ahmedabad (India) founded in 1995. The company has 26 employees. Divine Savior offers products and services including Rosuvastatin Calcium, Gabapentin And Methycobalamin Tablets, Glimepiride Metformin Voglibose Tablets, Spacer For Inhaler, and Budesonide Respirator Suspension. Divine Savior operates in a competitive market with competitors including AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
- Headquarter Ahmedabad, India
- Employees 26
- SectorsHealthcare
- Website divinesavior.co.in
- Legal Name Divine Savior Private Limited
- Date of Incorporation 01 Sep, 2011
- Jurisdiction Sanand, Gujarat, India
- Annual Revenue₹36.51 Cr
FY 2025 · +24% YoY
- Net Profit₹1.59 Cr
FY 2025 · 4% margin
- EBITDA₹2.84 Cr
FY 2025 · 8% margin
- Latest Funding Round$99.06K (USD), Grant
Jun 2021
- Investors
- Employee Count26
Associated legal entities of Divine Savior
Divine Savior operates through Divine Savior Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Divine Savior Private Limited CIN U24100GJ2011PTC066964 | Active | 01 Sep 2011 | Sanand, Gujarat | ₹36.5 Cr | 26 | 2 | View details |
Products & Services of Divine Savior
Divine Savior offers a comprehensive portfolio of products and services, including Rosuvastatin Calcium, Gabapentin And Methycobalamin Tablets, Glimepiride Metformin Voglibose Tablets, Spacer For Inhaler, and Budesonide Respirator Suspension.
Cholesterol-lowering tablet for heart disease management.
Medication for nerve pain and neurological conditions.
Tablets to control blood sugar in diabetes patients.
Device to improve inhaler medication delivery for asthma.
Nebulizer solution for treating respiratory inflammation.
Funding Insights of Divine Savior
- Total Rounds 1
- Last Round Grant — $99,058
- First Round $99,058
(Jun 2021)
- Investors Count 1
All 1 funding rounds of Divine Savior with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2021 | $99,058 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Divine Savior
Divine Savior has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Health Resources and Services Administration.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Health services and resources are provided by HRSA nationwide. | – | hrsa.gov | Rockville, United States |
Investor details for Divine Savior
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Divine Savior Private Limited (Divine Savior)
Divine Savior Private Limited is the primary company behind Divine Savior. The board of Divine Savior Private Limited currently have 2 directors; the longest-serving is Manoj Naranbhai Patel, appointed in 2011.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Manoj Naranbhai Patel DIN 01852382 | Director | 01 Sep 2011 | 15 yrs 1 mo | Divine Savior Private Limited |
| Rakesh Jyantilal Shah DIN 01852418 | Director | 01 Sep 2011 | 15 yrs 1 mo | Divine Savior Private Limited |
Financials of Divine Savior
Figures of Divine Savior Private Limited, the primary company behind Divine Savior, for FY 2025. Revenue was ₹36.51 Cr (+24% year on year). Net profit was ₹1.59 Cr (4% margin). EBITDA was ₹2.84 Cr (8% margin). Revenue has grown at a compounded annual rate of +22% over three years and +23% over five years.
- ₹36.51 CrRevenue · FY 2025 · +24% YoY
- ₹1.59 CrNet profit · 4% margin
- ₹2.84 CrEBITDA · 8% margin
- ₹1 LakhPaid-up capital
- 26Employees (provident fund records)
- +22%Revenue CAGR, 3 years
- +23%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Divine Savior Private Limited are on its company page.
Detailed financial statements for Divine Savior
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Divine Savior
2 dated milestones of Divine Savior across 26 years, from founding to its latest funding, stage changes and deals.
- Founded Divine Savior is founded.
- Funding First funding round of $99K.
Competitors of Divine Savior
Divine Savior operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amerisourcebergen.com | 1985 | Chesterbrook, United States | – | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | |
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $11.53M | 161 | Provider of medical equipment, devices, and drugs distribution services | |
| mahaveermedi.com | 2016 | Bengaluru, India | – | 588 | Serves as a distributor of a wide range of pharmaceutical drugs. | |
| dipnapharmachem.com | 2011 | Ahmedabad, India | – | – | Distributor of pharmaceutical raw materials |
Detailed competitors of Divine Savior
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Divine Savior
The website of Divine Savior (divinesavior.co.in) receives about 13.3K visits a month.
- Monthly visits13.3K
▲ 1239% vs previous month
Similar companies to Divine Savior
10 companies that operate in the same segment as Divine Savior (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Divine Savior
Divine Savior was founded in 1995 and raised its 1st funding round 26 years after it was founded.
Divine Savior is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Divine Savior has 26 employees.
The primary company behind Divine Savior, Divine Savior Private Limited, reported revenue of ₹36.51 Cr for FY 2025, up 24% year on year.
Divine Savior Pvt. Ltd. was established in 1995 in Ahmedabad, Gujarat, India, within the pharmaceutical sector. Operations center on the production of cardiovascular medicines, central nervous system (CNS) treatments, and anti-diabetic formulations. Manufacturing activities are conducted from facilities in the region, supporting distribution primarily in India. The companys online presence is maintained through the domain divinesavior.co.in, facilitating information access for stakeholders.
Divine Savior's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.
Divine Savior offers Rosuvastatin Calcium, Gabapentin And Methycobalamin Tablets, Glimepiride Metformin Voglibose Tablets, Spacer For Inhaler, and Budesonide Respirator Suspension.
Divine Savior has 1 investor. Key investors include Health Resources and Services Administration.
Divine Savior operates through Divine Savior Private Limited.
The legal entities of Divine Savior currently have 2 directors, including Manoj Naranbhai Patel, Rakesh Jyantilal Shah.